Delivery Order SPE2DB20D3303-SPE2DB25FA1XB
Award Date 7/29/25
Potential Completion Date 7/30/25
Potential Value $4.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Contrave ER 8-90 mg tablets (120 count units) valued at $2,707.41. This firm fixed-price delivery order, with an ultimate completion date of July 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered...
- The Defense Logistics Agency awarded a delivery order valued at $6,406.51 to AmerisourceBergen Drug Corp for Contrave ER 8-90 mg tablets (120 count) on August 1, 2025, with completion targeted for August 4, 2025. This competitively awarded, firm fixed-price delivery order utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $22,397.23 to AmerisourceBergen Drug Corp for Contrave ER 8-90 mg tablets (120 count) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $3,391.13 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count unit). This is a firm fixed-price, non-set-aside contract with a completion date of July 29, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,456.46 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $4,227.78 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Contrave ER 8-90 mg tablets (120 count). This non-competitive delivery order is structured as a firm fixed-price contract with a completion deadline of August 6, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. Contrave is a prescription weight-management medication combining naltrexone and bupropion, supporting the...
- The Defense Logistics Agency awarded a delivery order valued at $11,801.43 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120 count) on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Contrave is an FDA-approved prescription medication used for chronic weight...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,825.61 firm fixed-price delivery order is for the supply of Contrave ER 8-90 mg tablets, a medication used for weight management. The contract has an ultimate completion date of July 19, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a $10,587.49 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Contrave ER 8-90 mg tablets to support military treatment programs and facilities. The order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CONTRAVE ER 8-90 mg tablets. The award, valued at $23,339.77, has an ultimate completion date of August 13, 2024. The contract is a firm fixed-price delivery order without a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999...